WithdrawnPhase 4

SPY Angiography To Assist With Ulnar Nerve Transposition at the Elbow

Stopped: Obsolete study

United States0Started 2022-05-26

Plain-language summary

Patients with vascular disease, thyroid disease or an allergy to indocyanine green (ICG) will be excluded. Patients with either median or ulnar nerve compression will be treated with nerve decompression. SPY angiography will be used to assess the vascularity of the nerve both pre and post release as the primary outcome measure.

Who can participate

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 18 years old or older; male and female patients * Ulnar Nerve Compression at the Elbow * Failed conservative treatment (i.e. hand therapy, pain medications, splinting) * Able to provide informed consent Exclusion Criteria: * Pregnancy/breastfeeding * Thyroid Disease * Vascular Disease * Known allergy to any study drug

What they're measuring

Change in level of Fluorescence before and after nerve release.

Timeframe: 2 weeks, 6 weeks, 3 months, 6 months, and 12 months visits

Trial details

NCT IDNCT05332405

SponsorNYU Langone Health

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-10-01

View on ClinicalTrials.gov More Cubital Tunnel Syndrome trials